Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
05/2003
05/08/2003WO2003037311A2 Method for treating retroviral infections
05/08/2003US20030088103 PPARgamma modulators
05/08/2003US20030087930 Process for preparing 2-(4-chlorobenzolamino)-3[ (1h)-quinolinon-4-yl] propionic acid
05/08/2003US20030087929 Quinolinone derivative formulation and its production method
05/08/2003US20030087926 Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives
05/08/2003US20030087910 E.g., O-(2-quinolinylmethyl)-N-quinaldoyl-D,L-tyrosine
05/08/2003US20030087306 Methods for identifying novel multimeric agents that modulate receptors
05/08/2003US20030087126 Hydrocarbon compound, material for organic electroluminescent element and organic electroluminescent element
05/08/2003CA2465350A1 Therapeutic quinoline compounds with 5-ht-antagonistic properties
05/08/2003CA2465344A1 Therapeutic quinolone compounds with 5-ht-antagonistic properties
05/08/2003CA2465306A1 Substituted 1h-quinolin-2-one compounds
05/08/2003CA2465305A1 Antiretroviral pyridine and quinoline derivatives
05/08/2003CA2464303A1 Method for treating retroviral infections
05/07/2003EP1307429A1 Process for asymmetric synthesis of substituted 1,4-dihydropyridines
05/07/2003EP1086079B1 Derivatives of hydroxyphenylsulfanylbenzoic and hydroxyphenylsulfanylarylacetic acids
05/07/2003EP1054863B1 2-aminoquinoline derivatives having d4-agonistic activity
05/07/2003EP0841929B1 Quinolones and their therapeutic use
05/07/2003EP0765314B1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators
05/07/2003CN1107670C Process for prepn. of quinoline derivative and intermediate therefor
05/06/2003US6559308 The present invention relates to a method for preparing quinoxaline-5- and 6-carboxylic acids. The method comprises contacting an aqueous suspension of a 5- or 6-hydroxymethyl quinoxaline with oxygen in the presence of a transition metal
05/06/2003US6559176 A method for regulating the activity of an autoinducer-2 receptor comprising contacting an autoinducer-2 receptor with an AI-2 agonist or antagonist compound.
05/06/2003US6559163 Agonists, antagonists or inverse agonists for GABAA brain receptors; useful in diagnosis and treatment of anxiety, depression
05/02/2003EP1306372A1 Heterocycle derivatives and drugs
05/02/2003EP1305290A1 Novel heteroaryl derivatives and the use thereof as pharmaceuticals
05/02/2003EP1305048A2 Inhibitors of cellular efflux pumps of microbes
05/02/2003EP1139758B1 Fungicide mixture
05/02/2003EP0918761B1 Certain amido- and amino-substituted benzylamine derivatives; a new class of neuropeptite y1 specific ligands
05/02/2003EP0811006B1 Benzopyran-containing compounds and method for their use
05/02/2003EP0706396B1 1,2,3,4-tetrahydroquinoline-2,3,4-trione-3 or 4-oximes and use
05/01/2003WO2003035624A1 Quinoline compound
05/01/2003WO2003035618A2 Modulators of phosphoinositide 3-kinase
05/01/2003WO2003035602A1 Lipid modulators
05/01/2003WO2003035071A1 Stereospecific enrichment of heterocyclic enantiomers
05/01/2003WO2003035057A1 Inhibitors of dipeptidyl peptidase iv
05/01/2003WO2003034989A2 α-HYDROXYARYLBUTANAMINE INHIBITORS OF ASPARTYL PROTEASE
05/01/2003US20030083357 Oxime derivatives for the treatment of dyslipidemia and hypercholesteremia
05/01/2003US20030083267 For inhibiting the binding of ligands to antigens; prophylaxis and treatment of inflammatory and autoimmune diseases such as asthma, arthritis, psoriasis, transplantation rejection, multiple sclerosis, diabetes, and inflammatory bowel disease
05/01/2003US20030082631 Detecting modulator of peroxisome proliferator-activated receptor; obtain sample contain proxisome receptor, incubate with test agent, monitor sample for adjustment in receptor activity
05/01/2003CA2464981A1 Quinoline compound
05/01/2003CA2464659A1 Stereospecific enrichment of heterocyclic enantiomers
05/01/2003CA2464254A1 Inhibitors of post-proline cleaving proteases
04/2003
04/30/2003CN1414952A Heterocyclic compounds having sulfonic acid
04/30/2003CN1414849A Carboxylic acid amides, medicaments containing these compounds and the use and preparation thereof
04/30/2003CN1107061C Chemotaxis cell factor receptor-3 receptor antagonists
04/29/2003US6555577 Compounds, their preparation and use
04/29/2003US6555549 Useful in treating acne, baldness, prostatic cancer and hypertrophy in men and hirsutism in women
04/24/2003WO2003033617A1 Phosphorescent compounds and devices comprising the same
04/24/2003WO2003033484A1 Substituted piperazine cyclohexane carboxilic acid amides and the use thereof
04/24/2003WO2003033472A1 Quinoline or quinazoline derivatives inhibiting auto- phosphorylation of fibroblast growth factor receptors
04/24/2003WO2003033467A1 Nitroso diphenylamine derivatives as nitrogen monoxide generating agents
04/24/2003WO2003032999A1 Alkyne matrix metalloproteinase inhibitors
04/24/2003WO2003032972A1 5’-carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
04/24/2003WO2003032971A1 5’-acylamino-1,1’-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
04/24/2003WO2003032970A1 5'-carbamoyl-2'-methyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
04/24/2003WO2003032921A2 Treatment of neurodegenerative diseases and cancer of the brain
04/24/2003WO2003032910A2 Carbinols for the treatment of neuropathic dysfunction
04/24/2003US20030078270 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI
04/24/2003US20030078235 Treatment of central nervous system disorders; anticonvulsants, antiepileptics, neuroprotective agents and muscle relaxants
04/24/2003US20030077651 Novel support for synthesis and purification of compounds
04/24/2003CA2463518A1 Carbinols for the treatment of neuropathic dysfunction
04/24/2003CA2463426A1 Substituted piperazine cyclohexane carboxilic acid amides and the use thereof
04/24/2003CA2462442A1 Alkyne matrix metalloproteinase inhibitors
04/23/2003EP1304110A2 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
04/23/2003EP1303503A2 Aniline derivatives
04/23/2003EP1257537A4 Therapeutic morpholino-substituted compounds
04/23/2003EP0993442B1 Hydrazine derivatives
04/23/2003CN1413196A 2-Arylquinoline derivatives, preparation and therapeutic use thereof
04/23/2003CN1413181A Novel hydronaphtalene compounds prepared by phodium catalyzed ring opening reaction in presence of phosphine ligand
04/23/2003CN1412181A Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor
04/22/2003US6552034 Benzo[c]quinolizine derivatives, their preparation and use as 5α-reductases inhibitors
04/17/2003WO2003031436A1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract
04/17/2003WO2003031413A1 Quinoline derivatives, synthesis method, and medicines containing said derivatives
04/17/2003WO2003031410A1 Ligands of melanocortin receptors and compositions and methods related thereto
04/17/2003WO2003030846A1 Agent for coloring keratin fibers
04/17/2003WO2002096903A3 Chemical derivatives and the use thereof as an anti-telomerase agent
04/17/2003US20030073862 Antidiabetic agents, anticancer agents, anticholesterol agents
04/17/2003US20030073843 Methods for preparing CETP inhibitors
04/17/2003US20030073831 Continous separation of preferential compounds from sample; prepare liquid interphases, incubate with sample, recover compound
04/17/2003US20030073682 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors
04/17/2003US20030073582 Fused heterocyclic dicarboxylic acid diamide derivatives or salts thereof, herbicide and method for using the same
04/17/2003US20030072964 For producing high efficiency organic light emitting devices
04/17/2003CA2458456A1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract
04/16/2003EP1302461A1 Tnf-alpha production inhibitors
04/16/2003EP1301464A1 Biphenylcarboxylic acid amides, production thereof and use thereof as medicaments
04/16/2003EP0960099B1 Improved process for the preparation of halo-4-phenoxyquinolines
04/16/2003EP0880520B1 Benzo [c]quinolizine derivatives, their preparation and use as 5-alpha-reductases inhibitors
04/16/2003CN1411446A Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors
04/16/2003CN1105715C New pyridonecarboxylic acid derivatives or their salts and antibacterial agent comprising same as active ingredient
04/15/2003US6548671 Quinoxalinyl amide derivatives
04/15/2003US6548668 Stabilizer for proteins
04/15/2003US6548548 Cardiovascular disorders; anticholesterol agents
04/15/2003US6548547 Sulfonylamino carboxylic acid N-arylamides as guanylate cyclase activators
04/15/2003US6548524 Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors
04/15/2003US6548515 Use as anticancer agents
04/15/2003US6548504 Compounds
04/15/2003CA2053208C Hydroxyalkylquinoline ether acids as leukotriene antagonists
04/15/2003CA2051504C 1-phenyl-3-aryl-2-propyne-1-ones as calcium uptake inhibitors
04/10/2003WO2003029220A2 Preparation of an anhydrous quinoline-based cetp inhibitor by crystallization
04/10/2003WO2003029211A1 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor
04/10/2003WO2003029206A1 Preparation of hiv protease inhibitors
1 ... 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 ... 277